AT458483T - PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE

26 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims
Document	Office	Kind	Date
34259501	United States of America	P	2001-12-20
0241273	United States of America	W	2002-12-20

Family members, oldest first
Document	Office	Kind
CA2471059A1	Canada	A1	2003-07-03
WO03053366A2	World Intellectual Property Organization (WIPO)	A2	2003-07-03
AU2002366811A1	Australia	A1	2003-07-09
US2003162764A1	United States of America	A1	2003-08-28
WO03053366A3	World Intellectual Property Organization (WIPO)	A3	2004-01-29
KR20040068317A	Republic of Korea	A	2004-07-30
BR0215202A	Brazil	A	2004-10-13
EP1465631A2	European Patent Office (EPO)	A2	2004-10-13
MXPA04005862A	Mexico	A	2004-11-01
EA200400830A1	Eurasian Patent Organization (EAPO)	A1	2004-12-30
EP1465631A4	European Patent Office (EPO)	A4	2005-03-30
CN1620294A	China	A	2005-05-25
US2005119271A1	United States of America	A1	2005-06-02
JP2005517659A	Japan	A	2005-06-16
US6916804B2	United States of America	B2	2005-07-12
EA200600315A1	Eurasian Patent Organization (EAPO)	A1	2006-06-30
EA007468B1	Eurasian Patent Organization (EAPO)	B1	2006-10-27
AU2002366811B2	Australia	B2	2009-01-15
US7501407B2	United States of America	B2	2009-03-10
EA011809B1	Eurasian Patent Organization (EAPO)	B1	2009-06-30
EP1465631B1	European Patent Office (EPO)	B1	2010-02-24
AT458483TThis record	Austria	T	2010-03-15
ATE458483T1	Austria	T1	2010-03-15
JP4440642B2	Japan	B2	2010-03-24
DE60235500D1	Germany	D1	2010-04-08
CA2471059C	Canada	C	2011-04-26

1 legal event, as the office reported them to INPADOC

Legal events, newest first
	Event	Code
2010-08-15	Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER	RER

German: SELEKTIVE PYRIMIDIN-A2B-ANTAGONISTENVERBINDUNGEN, IHRE SYNTHESE UND VERWENDUNG
English: SELECTIVE PYRIMIDINE A2B ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE

CPC, 18: C07D239/48
A61P1/00
C07D401/12
A61P1/12
C07D403/12
A61P3/00
A61P3/10
A61P9/00
A61P9/10
A61P9/12
A61P11/06
A61P17/00
A61P17/04
A61P19/02
A61P27/02
A61P35/00
A61P37/08
A61P43/00
Filled: the office’s first classification
IPC, 40: A61K31 495
A61K31 50
A61K31 505
A61K31 506
A61K31 513
A61K31 519
A61K31 535
A61K31 5377
A61K31 55
A61K31 551
A61P1 00
A61P1 12
A61P11 06
A61P17 00
A61P17 04
A61P19 02
A61P27 02
A61P3 10
A61P35 00
A61P37 08
A61P43 00
A61P9 00
A61P9 10
A61P9 12
C07D239 02
C07D239 42
C07D239 48
C07D243 08
C07D401 12
C07D401 14
C07D403 12
C07D405 12
C07D405 14
C07D409 12
C07D409 14
C07D411 12
C07D413 12
C07D417 12
C07D471 10
C07D487 04

Pyrimidine a2b selective antagonist compounds, their synthesis and use